SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

Ageing patient populations and technological advancements are emerging as key drivers of healthcare innovation and delivery.

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize AMD at first.

The "Fluorescein Angiography Market by Type, by Application, by End-User, and By Region" report has been added to ...

A new study has revealed that managing eye conditions through enhanced optometric services at local optometrists, rather than relying solely on hospital eye services (HES), can significantly reduce ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

The following is a summary of “Neuroretinal and RPE changes and susceptibility to Age-Related Macular Degeneration: insights ...

Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...

Age-related macular degeneration (AMD) is the leading cause of vision loss for people over 65. We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any ...

Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema ... affected spectral domain optical coherence tomography (SD-OCT), had ...

SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, as of January 10, 2024 First wet AMD registrational trial ...